Gut microbiota in Parkinson disease in a northern German cohort F Hopfner, A Künstner, SH Müller, S Künzel, KE Zeuner, NG Margraf, ... Brain research 1667, 41-45, 2017 | 125 | 2017 |
Genetics of essential tremor: meta-analysis and review G Kuhlenbäumer, F Hopfner, G Deuschl Neurology 82 (11), 1000-1007, 2014 | 75 | 2014 |
Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis M Duering, A Karpinska, S Rosner, F Hopfner, M Zechmeister, N Peters, ... Human molecular genetics 20 (16), 3256-3265, 2011 | 75 | 2011 |
Genome-wide association study in essential tremor identifies three new loci SH Müller, SL Girard, F Hopfner, ND Merner, CV Bourassa, D Lorenz, ... Brain 139 (12), 3163-3169, 2016 | 62 | 2016 |
Four-repeat tauopathies TW Roesler, AT Marvian, M Brendel, NP Nykaenen, M Hoellerhage, ... Progress in neurobiology 180, 101644, 2019 | 43 | 2019 |
Knowledge gaps and research recommendations for essential tremor F Hopfner, D Haubenberger, WR Galpern, K Gwinn, A Van't Veer, S White, ... Parkinsonism & related disorders 33, 27-35, 2016 | 42 | 2016 |
The role of SCARB2 as susceptibility factor in Parkinson's disease F Hopfner, EC Schulte, B Mollenhauer, B Bereznai, F Knauf, P Lichtner, ... Movement Disorders 28 (4), 538-540, 2013 | 36 | 2013 |
Early‐and late‐onset essential tremor patients represent clinically distinct subgroups F Hopfner, A Ahlf, D Lorenz, S Klebe, KE Zeuner, G Kuhlenbäumer, ... Movement Disorders 31 (10), 1560-1566, 2016 | 35 | 2016 |
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features F Hopfner, B Schormair, F Knauf, A Berthele, TR Tölle, R Baron, C Maier, ... BMC neurology 11 (1), 1-8, 2011 | 33 | 2011 |
The etiology of essential tremor: Genes versus environment F Hopfner, RC Helmich Parkinsonism & related disorders 46, S92-S96, 2018 | 29 | 2018 |
Is essential tremor a single entity? F Hopfner, G Deuschl European journal of neurology 25 (1), 71-82, 2018 | 28 | 2018 |
Testing for alcohol sensitivity of tremor amplitude in a large cohort with essential tremor F Hopfner, T Erhart, K Knudsen, D Lorenz, SA Schneider, KE Zeuner, ... Parkinsonism & related disorders 21 (8), 848-851, 2015 | 27 | 2015 |
Rest tremor revisited: Parkinson’s disease and other disorders W Chen, F Hopfner, JS Becktepe, G Deuschl Translational neurodegeneration 6 (1), 1-8, 2017 | 25 | 2017 |
Progress of pharmacological approaches in Parkinson's disease KE Zeuner, E Schäffer, F Hopfner, N Brüggemann, D Berg Clinical Pharmacology & Therapeutics 105 (5), 1106-1120, 2019 | 20 | 2019 |
ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystonia UM Sheerin, SA Schneider, L Carr, G Deuschl, F Hopfner, M Stamelou, ... Neurology 82 (12), 1065-1067, 2014 | 18 | 2014 |
Topography of essential tremor W Chen, F Hopfner, S Szymczak, O Granert, SH Müller, G Kuhlenbäumer, ... Parkinsonism & related disorders 40, 58-63, 2017 | 16 | 2017 |
Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism C Jiang, F Hopfner, A Katsikoudi, R Hein, C Catli, S Evetts, Y Huang, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (7), 720-729, 2020 | 14 | 2020 |
β-adrenoreceptors and the risk of Parkinson's disease F Hopfner, GU Höglinger, G Kuhlenbäumer, A Pottegård, M Wod, ... The Lancet Neurology 19 (3), 247-254, 2020 | 14 | 2020 |
The impact of rare variants in FUS in essential tremor F Hopfner, G Stevanin, SH Müller, E Mundwiller, M Bungeroth, A Durr, ... Movement Disorders 30 (5), 721-724, 2015 | 12 | 2015 |
HTLV-1 associated myelopathy after renal transplantation F Gövert, A Krumbholz, K Witt, F Hopfner, T Feldkamp, K Korn, A Knöll, ... Journal of clinical virology: the official publication of the Pan American …, 2015 | 11 | 2015 |